One-Liner
A crowdsourced analytics platform that aggregates researcher submission outcome data across journals to reveal rejection patterns, reviewer bias trends, and submission timing intelligence — killed because the unique value requires a large data network first, preventing day-1 revenue from institutional buyers.
AI Thinking Process
Scale Shift: institutional research integrity monitoring scaled down to individual researcher tool. 21% of ICLR 2026 reviews were AI-generated; researchers have zero analytics about the system determining their career advancement.
Researcher-facing analytics service aggregating submission outcome data across journals — which journals desk-reject AI papers, which assign biased reviewers, average time-to-decision by subfield. Browser extension auto-captures submission confirmations to build the dataset.
WHO: Assistant professor in computer science submitting to NeurIPS/ICML. CURRENT: Submits blind, checks Twitter for anecdotes about reviewer quality. WHY-SURPRISED: $30B publishing industry with zero analytics tools for the supply side.
Publisher conflict of interest confirmed: Elsevier, Springer Nature, Wiley earn revenue from APCs and subscriptions — revealing their own algorithmic biases would embarrass editorial processes. They cannot build this. Pivot consideration: institutional buyer (university research office) at $5K-20K/year repositions from B2C to B2B.
Survived at 42% conviction. Biggest worry: will researchers trust a third-party tool with their submission data? Privacy architecture is critical.
SciRev confirmed as closer competitor than Pass 1 acknowledged: crowdsourced journal comparison for review duration and desk rejection rates. Non-profit, manual entry only, limited coverage. SciVal (Elsevier) and InCites (Clarivate) occupy institutional analytics budget line at $10K-$50K/year. CRITICAL: institutional market is occupied; unique value requires network that doesn't exist yet.
Killed: monetization fails charge-from-day-1 constraint. Cannot sell institutional dashboard without aggregate data network. Cannot charge meaningful individual subscription without network. SciRev existence validates as community resource not commercial product. Distribution gate failed: no credible path to 100 paying customers in a specific channel from day 1.
Kill Reason
The monetization pathway fails the charge-from-day-1 constraint. The unique value proposition (submission pattern intelligence) requires a crowdsourced data asset built over months. Without the network, the product is either personal submission tracking ($10/month, insufficient willingness to pay among academics who feel exploited by publishers) or institutional citation analytics (competing directly with SciVal and InCites at $10K-$50K/year). SciRev's existence as a free non-profit tool further validates this as a community resource rather than a commercial product.
Risk Analysis
Risk analysis available for latest engine ideas.
What do you think?
Related ideas you can explore free:
killed: The monetization pathway fails the charge-from-day-1 constraint. The unique value proposition (submission pattern intelligence) requires a crowdsourced data asset built over months. Without the network, the product is either personal submission tracking ($10/month, insufficient willingness to pay among academics who feel exploited by publishers) or institutional citation analytics (competing directly with SciVal and InCites at $10K-$50K/year). SciRev's existence as a free non-profit tool further validates this as a community resource rather than a commercial product.
killed: Open-source middleware (HAMi) already provides heterogeneous AI computing virtualization for free. Proprietary play is squeezed between free open-source and vertically integrated hardware vendor ecosystem.
killed: 5+ funded competitors including Cast AI ($1B valuation), OneChronos (backed by Nobel laureate), Akash Network (decentralized, 80% cheaper), Argentum AI (blockchain-settled). Market is claimed with massive capital.